Advisory Services Network’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.26M Sell
258,469
-10,327
-4% -$275K 0.1% 219
2025
Q4
$6.69M Sell
268,796
-43,076
-14% -$1.09M 0.09% 223
2025
Q3
$7.95M Sell
311,872
-38,138
-11% -$941K 0.12% 188
2025
Q2
$8.15M Sell
350,010
-9,202
-3% -$215K 0.13% 168
2025
Q1
$9.1M Buy
359,212
+19,407
+6% +$508K 0.17% 126
2024
Q4
$9.02M Buy
339,805
+11,502
+4% +$312K 0.17% 121
2024
Q3
$9.19M Hold
328,303
0.19% 106
2024
Q2
$9.19M Sell
328,303
-74,543
-19% -$2.05M 0.19% 106
2024
Q1
$11.2M Sell
402,846
-39,421
-9% -$1.09M 0.25% 80
2023
Q4
$12.7M Buy
442,267
+35,337
+9% +$1.07M 0.31% 59
2023
Q3
$13.5M Buy
406,930
+18,804
+5% +$665K 0.36% 49
2023
Q2
$14.2M Buy
388,126
+57,944
+18% +$2.26M 0.38% 45
2023
Q1
$13.5M Sell
330,182
-6,975
-2% -$301K 0.37% 40
2022
Q4
$17.3M Sell
337,157
-10,638
-3% -$510K 0.53% 20
2022
Q3
$15.2M Sell
347,795
-7,063
-2% -$343K 0.54% 22
2022
Q2
$18.6M Buy
354,858
+25,871
+8% +$1.32M 0.64% 16
2022
Q1
$17M Sell
328,987
-79,831
-20% -$4.14M 0.5% 24
2021
Q4
$24.1M Sell
408,818
-10,892
-3% -$540K 0.69% 13
2021
Q3
$18.1M Buy
419,710
+151,179
+56% +$6.7M 0.57% 16
2021
Q2
$10.5M Sell
268,531
-7,916
-3% -$308K 0.33% 47
2021
Q1
$10M Buy
276,447
+34,039
+14% +$1.21M 0.37% 40
2020
Q4
$8.92M Buy
242,408
+5,715
+2% +$210K 0.36% 48
2020
Q3
$8.24M Buy
236,693
+32,034
+16% +$1.12M 0.39% 45
2020
Q2
$6.35M Buy
204,659
+11,382
+6% +$387K 0.35% 60
2020
Q1
$5.98M Sell
193,277
-4,325
-2% -$147K 0.39% 47
2019
Q4
$7.34M Buy
197,602
+13,070
+7% +$466K 0.39% 45
2019
Q3
$7.58M Hold
184,532
0.46% 37
2019
Q2
$7.58M Buy
184,532
+8,635
+5% +$343K 0.47% 37
2019
Q1
$7.09M Sell
175,897
-3,360
-2% -$135K 0.5% 32
2018
Q4
$7.42M Sell
179,257
-4,670
-3% -$194K 0.65% 21
2018
Q3
$7.69M Buy
183,927
+10,927
+6% +$421K 0.56% 22
2018
Q2
$6.26M Sell
173,000
-14,185
-8% -$485K 0.48% 31
2018
Q1
$6.3M Buy
187,185
+765
+0.4% +$26.3K 0.5% 27
2017
Q4
$6.41M Buy
186,420
+44,836
+32% +$1.53M 0.56% 19
2017
Q3
$4.8M Sell
141,584
-3,446
-2% -$111K 0.55% 23
2017
Q2
$4.62M Sell
145,030
-370
-0.3% -$11.7K 0.6% 12
2017
Q1
$4.72M Buy
+145,400
New +$4.58M 0.69% 12
2016
Q3
$3.9M Buy
121,247
+5,656
+5% +$189K 0.73% 12
2016
Q2
$3.86M Buy
115,591
+35,306
+44% +$1.13M 0.88% 8
2016
Q1
$2.26M Buy
80,285
+38,971
+94% +$1.11M 0.62% 26
2015
Q4
$1.26M Buy
41,314
+857
+2% +$27K 0.41% 51
2015
Q3
$1.21M Buy
40,457
+1,149
+3% +$36.8K 0.36% 50
2015
Q2
$1.26M Buy
39,308
+1,584
+4% +$51.6K 0.37% 41
2015
Q1
$1.23M Buy
37,724
+9,007
+31% +$286K 0.34% 50
2014
Q4
$902K Buy
28,717
+1,153
+4% +$33.1K 0.28% 79
2014
Q3
$773K Buy
27,564
+4,954
+22% +$139K 0.28% 87
2014
Q2
$637K Buy
22,610
+1,273
+6% +$36.3K 0.27% 98
2014
Q1
$650K Buy
21,337
+559
+3% +$16.7K 0.34% 85
2013
Q4
$604K Buy
20,778
+6,136
+42% +$179K 0.3% 78
2013
Q3
$399K Sell
14,642
-264
-2% -$7.18K 0.34% 63
2013
Q2
$400K Buy
+14,906
New +$412K 0.33% 60

Other funds holding PFE

Advisory Services Network's PFE Position: Q1 2026 in Review

Advisory Services Network reduced its Pfizer (PFE) stake by 3.8% in Q1 2026, selling an estimated $275K and leaving 258,469 shares worth $7.26M. The position accounts for 0.1% of the portfolio, ranked #219.

Advisory Services Network first reported a position in PFE in Q2 2013 and has held it in 51 quarters since. The position peaked at $24.1M in Q4 2021. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Advisory Services Network held 258,469 shares of Pfizer worth $7.26M as of Q1 2026.
  • Advisory Services Network sold 10,327 Pfizer shares in Q1 2026, an estimated $275K.
  • Pfizer made up 0.1% of Advisory Services Network's portfolio in Q1 2026, its #219 holding.
  • Advisory Services Network first reported a position in Pfizer in Q2 2013 and has held it in 51 quarters since.
  • Advisory Services Network's Pfizer position peaked at $24.1M in Q4 2021.
  • 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Advisory Services Network's 13F filing for Q1 2026, filed 15 May 2026.